P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES

• Michael Robert Savona,
• James K Mccloskey,
• Elizabeth A. Griffiths,
• Karen Yee,
• Amer M. Zeidan,
• Aref Al-Kali,
• H. Joachim Deeg,
• Prapti A. Patel,
• Mitchell Sabloff,
• Mary-Margaret Keating,
• Nancy Y Zhu,
• Nashat Gabrail,
• Salman Fazal,
• Joseph J. Maly,
• Olatoyosi Odenike,
• Hagop Kantarjian,
• Amy Dezern,
• Casey L Oconnell,
• Gail Roboz,
• Lambert Busque,
• Rena Buckstein,
• Harshad Amin,
• Jasleen K Randhawa,
• Brian Leber,
• Kim-Hien Dao,
• Winny Chan,
• Aram Oganesian,
• Yuri Sano,
• Beloo Mirakhur,
• Harold Keer,
• Guillermo Garcia-Manero

Affiliations

Michael Robert Savona

1 Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, United States

James K Mccloskey

2 John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, United States

Elizabeth A. Griffiths

3 Roswell Park Comprehensive Cancer Center, New York, United States

Karen Yee

4 Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

Amer M. Zeidan

5 [email protected], New Haven, United States

Aref Al-Kali

6 Mayo Clinic, Rochester, Rochester, United States

H. Joachim Deeg

7 Fred Hutchinson Cancer Research Center, Seattle

Prapti A. Patel

8 University of Texas Southwestern Medical Center, Dallas, United States

Mitchell Sabloff

9 Division of Hematology, Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Canada, Ottawa, Ontario, Canada

Mary-Margaret Keating

10 Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

Nancy Y Zhu

11 University of Alberta Hospital - Hematology Research, Edmonton, Alberta

Nashat Gabrail

12 Gabrail Cancer Center Research, Canton, United States

Salman Fazal

13 West Penn Hospital, Allegheny Health Network, Pittsburgh, United States

Joseph J. Maly

14 Norton Cancer Institute, Louisville, United States

Olatoyosi Odenike

15 University of Chicago, Chicago, United States

Hagop Kantarjian

16 The University of Texas MD Anderson Cancer Center, Houston, United States

Amy Dezern

17 Johns Hopkins University Hospital, Baltimore, United States

Casey L Oconnell

18 USC Keck School of Medicine, University of Southern California, Los Angeles, United States

Gail Roboz

19 Weill Cornell Medicine, The New York Presbyterian Hospital, New York, United States

Lambert Busque

20 Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada

Rena Buckstein

21 Odette Cancer Center, Sunnybrook Health, Toronto, Ontario, Canada

Harshad Amin

22 Boca Raton Cancer Research, Plantation, United States

Jasleen K Randhawa

23 Houston Methodist Cancer Center, Houston, United States

Brian Leber

24 Juravinski Cancer Centre, Hamilton, Ontario, Canada, Hamilton, Ontario, Canada

Kim-Hien Dao

25 Astex Pharmaceuticals, Inc., Pleasanton, United States

Winny Chan

25 Astex Pharmaceuticals, Inc., Pleasanton, United States

Aram Oganesian

25 Astex Pharmaceuticals, Inc., Pleasanton, United States

Yuri Sano

25 Astex Pharmaceuticals, Inc., Pleasanton, United States

Beloo Mirakhur

25 Astex Pharmaceuticals, Inc., Pleasanton, United States

Harold Keer

25 Astex Pharmaceuticals, Inc., Pleasanton, United States

Guillermo Garcia-Manero

16 The University of Texas MD Anderson Cancer Center, Houston, United States